A

Axsome Therapeutics, Inc.

AXSM NASDAQ Healthcare · Biotechnology www.axsome.com
$206.43
Mkt Cap 10.62B
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$776.6M
133.7% CAGR
FCF TTM
-$71.4M
-9.2% margin
Running full 6-factor analysis…